Good morning :)
$
₹
A

Alpha Tau Medical Ltd. Warrant

DRTSW

NASDAQ
A

Alpha Tau Medical Ltd. Warrant

DRTSW

NASDAQ
$4.217.39% (+0.29)
$
₹
$4.217.39% (+0.29)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Unknown

Sector and industry information not available

Unknown

Recent listing (market-cap unavailable as on date)

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

—
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.

Peers

Peers

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Financials

Financials

Income

Balance Sheet

Cash Flow

-11.6
-12.1
-22.9
-45.8
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue000000000-
Net Income-7.98-7.36-6.92-9.47-8.69-10.11-11.68-12.13-22.93-45.81
Net Profit Margin----------
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Alpha Tau Medical Ltd. Warrant (DRTSW) share price today is $4.21 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $4.27 and a day low of $3.82.

  2. Alpha Tau Medical Ltd. Warrant stock trades on NASDAQ under the ticker symbol DRTSW.

  3. Alpha Tau Medical Ltd. Warrant's market capitalization is N/A as of September 5, 2026 at 1:30 AM IST.

  4. Alpha Tau Medical Ltd. Warrant's price-to-earnings (P/E) ratio is N/A as of September 4, 2026.

  5. Alpha Tau Medical Ltd. Warrant's price-to-book (P/B) ratio is 0 as of September 4, 2026.

  6. Yes, You can buy Alpha Tau Medical Ltd. Warrant shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Alpha Tau Medical Ltd. Warrant shares in three steps: 1. Search Alpha Tau Medical Ltd. Warrant on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Alpha Tau Medical Ltd. Warrant trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Alpha Tau Medical Ltd. Warrant (DRTSW) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.3752 shares at the current price of $4.21.

Loading...